Sign in

CVS HEALTH (CVS)

CVS Health Corporation is a leading health solutions company that operates across four main segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other . The company offers a wide range of health insurance products and services, pharmacy benefit management solutions, and retail pharmacy operations . CVS Health leverages its integrated model to enhance care delivery, improve health outcomes, and reduce health care costs .

  1. Pharmacy & Consumer Wellness - Operates retail pharmacy services, long-term care pharmacy services, specialty and mail order pharmacy offerings, and front store sales, which include health and wellness products and general merchandise .
  2. Health Care Benefits - Offers health insurance products and services, including medical, pharmacy, dental, and behavioral health plans, as well as Medicare Advantage and Medicaid management services .
  3. Health Services - Provides pharmacy benefit management solutions and health care services through medical clinics, virtual platforms, and home-based care, supported by acquisitions like Signify Health and Oak Street Health .
  4. Corporate/Other - Includes management and administrative expenses and products for which the company no longer solicits new customers .

You might also like

NamePositionExternal RolesShort Bio

Karen S. Lynch

ExecutiveBoard

President and CEO

None

Karen Lynch has been CEO since February 2021, leading CVS's transformation into a consumer-centric healthcare company.

J. David Joyner

Executive

President and CEO

Advisory Council Member, Rawls College of Business, Texas Tech University

Appointed CEO in October 2024; previously EVP and President of Pharmacy Services.

Prem S. Shah

Executive

EVP and Group President

None

Oversees CVS Caremark, CVS Pharmacy, and healthcare delivery businesses; joined CVS in 2013.

Samrat S. Khichi

Executive

EVP, Chief Policy Officer, and General Counsel

None

Joined CVS in February 2023; oversees public policy, compliance, and legal functions, and supported major acquisitions.

Steve Nelson

Executive

EVP and President of Aetna

None

Former CEO of UnitedHealthcare; leads Aetna's operations and strategy.

Thomas F. Cowhey

Executive

EVP and CFO

None

Appointed CFO in January 2024 after serving as interim CFO; oversees financial strategy and operations.

Tilak Mandadi

Executive

EVP, Chief Digital, Data, Analytics, and Technology Officer

None

Leads CVS's digital transformation, driving innovation and customer engagement; joined in July 2022.

Alecia A. DeCoudreaux

Board

Director

Lead Independent Trustee, Parnassus Funds

Former President of Mills College; brings pharmaceutical and corporate governance expertise.

Anne M. Finucane

Board

Director

Chair, Rubicon Carbon; Senior Advisor, TPG Climate Rise Fund; Director, Williams Sonoma

Former Vice Chair at Bank of America; recognized for ESG leadership and corporate strategy expertise.

C. David Brown II

Board

Director

Partner, Nelson Mullins Riley & Scarborough LLP

Legal expert with extensive healthcare governance experience; joined CVS Board in 2007.

Doug Shulman

Board

Director

Chairman and CEO, OneMain Holdings; Board Member, Carnegie Foundation for the Advancement of Teaching

Former IRS Commissioner; brings financial and regulatory expertise.

Fernando Aguirre

Board

Director

Director, Barry Callebaut AG; Director, Synchrony Financial

Former CEO of Chiquita Brands; brings global business and brand management expertise.

Guy Sansone

Board

Director

Chairman and CEO, H2 Health; Lead Independent Director, Pediatrix Medical Group; Board Member, ChenMed

Healthcare advisor and investor with over 30 years of experience in strategy and operations.

J. Scott Kirby

Board

Director

CEO, United Airlines; Chairman, Star Alliance Chief Executive Board

CEO of United Airlines; brings expertise in marketing, sales, and network planning.

Jean-Pierre Millon

Board

Director

None

Former CEO of PCS Health Systems; brings pharmacy benefit management and pharmaceutical expertise.

Jeffrey R. Balser

Board

Director

President and CEO, Vanderbilt University Medical Center; Dean, Vanderbilt University School of Medicine

Brings expertise in healthcare delivery, personalized medicine, and financial oversight.

Larry Robbins

Board

Director

CEO, Glenview Capital Management; Lead Independent Director, Butterfly Network

Founder of Glenview Capital; brings extensive healthcare investment expertise.

Leslie Norwalk

Board

Director

Board Member, Arvinas, ModivCare, Neurocrine Biosciences, Globus Medical

Former Acting Administrator of CMS; brings healthcare policy and regulatory expertise.

Mary L. Schapiro

Board

Director

Director, Morgan Stanley; Vice Chair, Bloomberg L.P.

Former SEC Chair; brings expertise in legal, regulatory compliance, and corporate governance.

Michael F. Mahoney

Board

Director

Chairman, President, and CEO, Boston Scientific Corporation

CEO of Boston Scientific; brings healthcare innovation and operational expertise.

Nancy-Ann M. DeParle

Board

Director

Managing Partner, Consonance Capital Partners; Director, HCA Healthcare; Trustee, Duke University

Former White House healthcare policy leader; brings over 25 years of healthcare sector experience.

Roger N. Farah

Board

Executive Chair of the Board

Director, The Progressive Corporation

Former Chair of the Board; brings over 40 years of retail industry experience.

  1. Given that your Health Care Benefits segment may show operating losses in 2024 after generating over $5.5 billion in adjusted operating income in 2023 , what are the primary factors driving this significant decline, and what specific measures are you implementing to return this business to profitability?

  2. You acknowledged miscalculations during the 2023 bid process for Medicare Advantage and individual exchange products, which significantly burdened Aetna's current results . How are you adjusting your bid and pricing strategies to prevent similar issues in future cycles, and what oversight mechanisms are being implemented to ensure accuracy?

  3. With the anticipated Medicare Advantage membership disenrollment of 5% to 10% due to benefit design changes and reduced supplemental benefits , how do you plan to maintain market competitiveness and member satisfaction while aiming for margin improvement?

  4. The individual exchange business is facing higher utilization and may result in negative margins approaching double digits . What are the underlying factors contributing to this underperformance, and what corrective actions are you taking to stabilize and improve this business line?

  5. Given that Aetna has been more acutely impacted by industry pressures than others , what structural or operational deficiencies have you identified, and how will the recent leadership changes and operational enhancements address these issues effectively?

Program DetailsProgram 1Program 2
Approval DateDecember 9, 2021November 17, 2022
End Date/DurationNot specifiedNot specified
Total additional amount$10.0 billion $10.0 billion
Remaining authorization amount$1.5 billion $10.0 billion
DetailsNo specific end date providedNo shares repurchased yet

Competitors mentioned in the company's latest 10K filing.

CompanyDescription

The retail pharmacy business is highly competitive, and the company competes with other drugstore chains, including this competitor, in the areas it serves. The competition is based on store location and convenience, customer service and satisfaction, product selection and variety, and price.

Rite Aid

The retail pharmacy business is highly competitive, and the company competes with other drugstore chains, including this competitor, in the areas it serves. The competition is based on store location and convenience, customer service and satisfaction, product selection and variety, and price.

The company competes with discount retailers, including this competitor, in the areas it serves. The competition is based on store location and convenience, customer service and satisfaction, product selection and variety, and price.

The company competes with online retailers, including this competitor, in the areas it serves. The competition is based on store location and convenience, customer service and satisfaction, product selection and variety, and price.

PharMerica

The company's largest LTC pharmacy competitor nationally is this competitor. The company also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities, and local retail pharmacies.

Prime Therapeutics

The Health Services segment has a significant number of competitors offering PBM services, including large, national PBM companies such as this competitor.

MedImpact

The Health Services segment has a significant number of competitors offering PBM services, including large, national PBM companies such as this competitor.

Express Scripts

The Health Services segment competes with PBMs owned by large national health plans, including the business of this competitor.

OptumRx

The Health Services segment competes with PBMs owned by large national health plans, including the business of this competitor.

Aledade

The company's primary care operations compete with large and medium-sized local and national providers of primary care services, such as this competitor.

Centerwell

The company's primary care operations compete with large and medium-sized local and national providers of primary care services, such as this competitor.

Collaborative Health Systems

The company's ACO operations compete with healthcare risk management providers, including this competitor, which operates nationally.

The company's ACO operations compete with healthcare risk management providers, including this competitor, which operates nationally.

Vytalize Health

The company's ACO operations compete with healthcare risk management providers, including this competitor, which operates nationally.

Stellar Health

The company's ACO operations compete with healthcare risk management providers, including this competitor, which operates nationally.

Equality Health

The company's ACO operations compete with healthcare risk management providers, including this competitor, which is more geographically focused.

Physicians of Southwest Washington

The company's ACO operations compete with healthcare risk management providers, including this competitor, which is more geographically focused.

Matrix Medical Network

The company's IHE and related services operations compete with a wide variety of local and national providers of in-home, virtual, and in-person diagnostic and evaluative services, including pure-play companies whose principal business is providing health risk assessments and similar services, such as this competitor.

NameStart DateEnd DateReason for Change
Ernst & Young LLP2007 PresentCurrent auditor

Notable M&A activity and strategic investments in the past 3 years.

CompanyYearDetails

Oak Street Health, Inc.

2023

Acquired by CVS Health on May 2, 2023 for $39.00 per share in cash, financed through $5.0 billion in borrowings and existing cash resources to expand its value-based primary care strategy; final purchase accounting adjustments were completed in Q2 2024.

Signify Health, Inc.

2023

Acquisition completed in 2023; CVS Health acquired the company to leverage its expertise in health risk assessments, value-based care, and provider enablement services, with integration costs recorded in 2024 under the Corporate/Other segment.

Recent press releases and 8-K filings for CVS.

CVS Health unveils 2026 Aetna Medicare Advantage plans
·$CVS
Product Launch
  • CVS Health’s Aetna will offer 2026 Medicare Advantage Prescription Drug plans in 43 states plus Washington, D.C., covering 57 million Medicare-eligible beneficiaries.
  • All MA plans feature a $0 monthly premium in every available county and $0 copays for Tier 1 drugs, colonoscopies and mammograms at in-network providers.
  • Supplemental benefits include dental, vision and hearing coverage with $0 routine exams, a SilverSneakers fitness membership, and an annual Healthy Home Visit at no cost.
  • Special Needs Plans expand with C-SNPs in 18 states (16 new) and D-SNPs in 119 new counties, offering $0 condition-related copays and allowances on an Extra Benefits Card.
  • Prescription drug benefits feature a $2,100 annual out-of-pocket maximum, $0 coverage on Tier 1–2 drugs for MAPD members, and an interest-free Medicare Prescription Payment Plan.
7 days ago
CVS subsidiary Omnicare initiates Chapter 11 restructuring
·$CVS
Legal Proceedings
Debt Issuance
  • Omnicare, a wholly owned indirect subsidiary of CVS Health, has voluntarily filed for Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas to address litigation-related damages and broader industry challenges.
  • The company secured $110 million of debtor-in-possession financing, which, together with operating cash flow, is expected to fund ongoing obligations pending court approval.
  • Omnicare will continue providing pharmacy and clinical services to long-term care facilities without disruption and plans to maintain uninterrupted payment of employee wages and vendor obligations under normal terms.
  • The restructuring process will evaluate both standalone restructuring and potential sale options while remaining focused on customer support and service delivery.
Sep 22, 2025, 8:19 PM
CVS Health’s Omnicare unit files Chapter 11 after $949 M penalty
·$CVS
Legal Proceedings
Debt Issuance
  • CVS Health’s Omnicare unit has filed for Chapter 11 bankruptcy in the Northern District of Texas to manage a $949 million legal penalty stemming from alleged fraudulent prescription claims.
  • Omnicare listed assets of at least $100 million and liabilities of $1–10 billion, with the $949 million civil judgment as its largest unsecured debt.
  • The filing includes $110 million in debtor-in-possession financing to maintain operations and ensure no disruption to services, employees, or vendors.
  • CVS Health contends the penalty is “unconstitutional” and continues to dispute the jury’s ruling while exploring restructuring or sale options for Omnicare.
Sep 22, 2025, 5:20 PM
CVS Health subsidiary Omnicare initiates voluntary Chapter 11 process
·$CVS
Legal Proceedings
Debt Issuance
  • Omnicare, a CVS Health subsidiary, filed voluntary Chapter 11 in the Northern District of Texas to address recent litigation and broader long-term care pharmacy challenges while maintaining service levels to customers and residents.
  • The company secured $110 million in debtor-in-possession financing to ensure sufficient liquidity to meet ongoing obligations during the restructuring process.
  • Omnicare plans to evaluate a standalone restructuring or sale strategy as part of its court-supervised process.
  • During the proceedings, it will continue uninterrupted payment of employee wages, benefits, and vendor obligations under normal terms.
Sep 22, 2025, 5:01 PM
CVS Health reports strong segment performance and raises full-year guidance
·$CVS
Guidance Update
Revenue Acceleration/Inflection
Dividends
  • Shares are up over 58% YTD, driven by outperformance across all three businesses and a turnaround in managed care.
  • The healthcare benefits division saw ~12% revenue growth and ~40% operating income growth YoY, with a medical benefits ratio of 89.9%, 80 bps better than consensus.
  • All segments topped expectations, including a $0.35 EPS beat on a $1.46 basis and a $1.5 billion revenue beat from the pharmacy business; health services revenue was up 10.2%.
  • Management raised full-year guidance, adding $9 billion to revenue forecasts and boosting earnings outlook by $0.25 at the midpoint.
  • Valuation is attractive at 11× the midpoint of 2025 EPS guidance, with a 3.7% dividend yield on an annual payout of $2.66.
Aug 25, 2025, 11:46 PM
CVS Health upgraded to Buy by UBS
·$CVS
  • UBS raises CVS Health’s rating from Neutral to Buy and increases its price target to $79 from $67, an 18% hike.
  • Analyst projects 14% EPS CAGR through 2028, outpacing the 12% Wall Street consensus, based on strong recent performance.
  • CVS shares are up 53% year-to-date, with UBS estimating a further 15% upside potential.
  • Upgrade reflects momentum in healthcare benefits, including repricing ~50% of multi-year Medicare Advantage contracts.
Aug 18, 2025, 9:20 AM
CVS Health issues $4.0 billion of senior notes
·$CVS
Debt Issuance
  • On August 11, 2025, CVS Health entered into an Underwriting Agreement to issue and sell $4.0 billion of senior notes in four tranches, with settlement on August 15, 2025.
  • The offerings comprise $750 million of 5.000% Senior Notes due 2032, $1,500 million of 5.450% Senior Notes due 2035, $1,250 million of 6.200% Senior Notes due 2055 and $500 million of 6.250% Senior Notes due 2065.
  • Notes priced at approximately 99.6%–99.97% of par, implying yields of 5.051%–6.277% based on respective benchmark Treasuries, with T+4 settlement on August 15, 2025.
  • Net proceeds are approximately $3.958 billion after underwriting discounts and estimated offering expenses.
Aug 15, 2025, 12:00 AM
CVS Health reports Q2 2025 results
·$CVS
Earnings
Guidance Update
  • CVS Health reported Q2 revenues of $99 billion (+8% YoY), adjusted operating income of $3.8 billion (+2%), and adjusted EPS of $1.81 (flat YoY).
  • The company raised its full-year 2025 guidance to adjusted EPS of $6.30–$6.40 and now expects revenues of at least $391.5 billion.
  • By segment: Health Care Benefits delivered $36 billion revenue (+11%) and $1.3 billion adjusted operating income (+40%) ; Health Services posted $46 billion revenue (+10%) and $1.6 billion adjusted operating income (–18%) ; Pharmacy & Consumer Wellness generated $33 billion revenue (+12%) and $1.3 billion adjusted operating income (+8%).
  • Year-to-date cash flow from operations reached $6.5 billion, with $2.4 billion in cash on hand and improving leverage since year-end 2024.
  • CVS committed $20 billion over the next decade to transform health care and scheduled an Investor Day for December 9, 2025.
Jul 31, 2025, 5:05 PM
CVS Health launches Aetna Care Paths and AI-driven digital tools
·$CVS
Product Launch
New Projects/Investments
  • Aetna introduced Aetna Care Paths in the Aetna Health app, offering personalized benefit information and care recommendations via US patent-pending technology.
  • AI-driven clinical solutions will free up 90 minutes per day for nurses, enabling more one-on-one member engagement.
  • This launch is part of a $20 billion multi-year digital investment aimed at simplifying healthcare navigation and enhancing member and provider experience.
  • Additional app enhancements include vaccine scheduling, claims visualization with a “donut” chart, AI chat support, Smart Compare provider matching, and dark mode accessibility.
  • Other new AI-powered features enable provider availability validation via claims data, personalized cost tracking and AI-driven bill matching for streamlined claims submission.
Jul 29, 2025, 11:00 AM
CVS Health Corp prefers Wegovy over Zepbound; waste stocks offer buying opportunity
·$CVS
  • CVS’s PBM Caremark will prefer Wegovy over Zepbound, shifting coverage to Novo’s product and affecting 200,000 Zepbound patients who must switch or pay out-of-pocket.
  • In the GLP-1 obesity market, Zepbound holds 60% market share and accounts for 75% of treatment starts, underscoring strong patient preference despite CVS’s formulary move.
  • Waste management equities have sold off, now trading at an 8% EV/EBITDA premium to the S&P 500 versus a 15–20% historical premium, creating a buying opportunity ahead of a looming landfill capacity squeeze (half of US landfills projected to close by 2050).
  • Casella Waste Systems is highlighted as the top pick for its pure-play waste and recycling model, expansive M&A runway across 10 states, and forecast double-digit free cash flow growth over the next several years.
Jul 23, 2025, 2:00 PM